Epigenetic-based differentiation therapy for Acute Myeloid Leukemia.

Both CM-444 and CM-1758 inhibited tumor growth significantly or very close to significance in the case of CM-444 in the MV4-11 model (Fig. 3B and Supplementary Fig. 4B ).

also in 56 other papers